GlassScriptPhysician profile
Colin Buday
NPI 1689318362
$765.67
in general payments reported to CMS, 2019-2025
9 companies · $525 in 2025
The $525 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.58 · 2023: $116 · 2024: $46.04 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403 · Travel and Lodging: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.23 |
| Travel and Lodging | $283.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $363.76 | 2025 | Accolade Sr |
| Abbott Laboratories | $126.83 | 2025 | Proclaim |
| Ipsen Biopharmaceuticals, INC | $65.15 | 2023-2024 | Dysport |
| Csl Behring | $27.58 | 2024 | Hizentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.23 | 2023 | Ofev |
| Averitas Pharma INC. | $22.69 | 2023 | Qutenza |
| Alexion Pharmaceuticals, INC. | $21.45 | 2023 | Strensiq |
| Abbvie INC. | $17.67 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $16.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Buday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.